left ventricular dysfunction
37% risk reduction for progression to symptomatic heart failure can be       achieved with ACE-inhibition in asymptomatic patients with systolic left       ventricular dysfunction (55).
37% risk reduction for progression to symptomatic heart failure can be       achieved with ACE-inhibition in asymptomatic  @OBJECT$   @PREDICAT$  systolic  @SUBJECT$  (55).